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CF. Conclusion: Increased MMP-2 activity in chronic AR may result in part from AR-
induced downregulation of TIMPs, with subnormal inhibition of MMP. Pharmacological
targeting of the MMP/TIMP-system may be effective in normalizing remodeling in AR. 
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1086-135 The Modified Ross Procedure in Patients With Aortic 
Dilatation
Paul Stelzer, Charles Geller, Robert Tranbaugh, Beth Israel Medical Center, New York, 
NY
Background: The Ross Procedure (pulmonary autograft replacement of the aortic valve)
has become a very useful option in young patients with isolated aortic valve disease.
There has been concern about using this option in patients with ascending aortic dilata-
tion or aneurysm. This study was designed to examine whether an aggressive approach
to repairing or replacing the dilated ascending aorta could be safely combined with the
modified Ross Procedure.
Methods: Fifty-six of 339 consecutive adult patients undergoing the modified Ross Pro-
cedure over 16 years had replacement (15) or reduction (41) of the ascending aorta. This
included 47 men and 9 women with an average age of 43.8 years. Of the 15 graft
replacement patients, the autograft root was supported with either an external “jacket” of
graft material (10) or residual native aorta (3). Thirteen graft replacement patients
required hypothermic circulatory arrest averaging 20 minutes. Thirty-seven patients had
elliptical lateral aortorrhaphy and 4 had closed plication. Cardiac ischemic time averaged
180 minutes for graft replacement and 156 minutes for aortorrhaphy versus 145 minutes
for patients without concomitant procedures.
Results: There was one operative death (from sepsis) for a 1.8% mortality compared to
2.2% (6/283) without ascending aortic surgery. Two other patients survived major compli-
cations – right ventricular failure and reversible neurologic deficit. Discharge echocardio-
grams of the 55 survivors revealed no or trace aortic regurgitation in 39 and mild in 16
patients. All returned to Class I functional status. No patients have required further sur-
gery. Follow up echo data show only one patient (un-“jacketed”) with evidence of root
dilatation.
Conclusion: The modified Ross Procedure can be safely extended to include patients
with a dilated or aneurysmal ascending aorta using an aggressive approach to repair or
replacement.
1086-136 Tissue Engineered Heart Valve Conduits of Porcine or 
Human Origin Differ Importantly in Chemotactic Activity 
for Monocytic Cells
Erwin Rieder, Marie-Theres Kasimir, Gernot Seebacher, Ernst Wolner, Paul Simon, 
Guenter Weigel, University Vienna, Vienna, Austria
Background: To overcome the obstacles of conventional heart valve substitutes an
already clinically applied approach is to decellularize xenogenous or allograft valves. As
these prostheses are considered to be non-antigenic and thus superior to cryopreserved
valve allografts, the aim of this study was to examine a remaining chemotactic activity of
porcine and human acellular valve matrices.
Methods: Porcine and human pulmonary valves were decellularized using a detergent-
based method. Soluble matrix proteins of the acellular tissue were extracted and chemo-
tactic activity for U937 monocytic cells was examined in a transmigration-chamber.
Native porcine and cryopreserved valve allograft tissue was used as positive control. To
detect residual soluble proteins within the matrix, protein-electrophoresis was performed.
Results: A significantly reduced (p<0,05) cell migration was seen comparing the cryo-
preserved allograft tissue (746,4 ± 136,1 cells/µl ± SEM in lower chamber, n=10) and the
decellularized porcine valve conduit tissue (183,6 ± 18,7, n=10). Surprisingly, the chemo-
tactic activity of acellular human valve tissue (34,6 ± 8,6, n=10) was similar to the nega-
tive control (39,2 ±6,6 cells/µl, n=10) and significantly lower (p<0,001) than the
decellularized porcine valve matrix. Electrophoresis of the acellular xenogeneic tissue
revealed that considerable amounts of soluble proteins with different molecular weights
remain in the porcine matrix which were not detected in the decellularized human valve
tissue.
Conclusion: We describe for the first time that the remaining immunogenic activity
strongly depends on the source of a tissue engineered heart valve. Whereas the acellular
porcine pulmonary valve does not result in the considered inert heart valve scaffold and
thus might induce an immunological response, the decellularization of a human pulmo-
nary heart valve diminishes the chemotactic activity of the valve tissue. This findings will
have an important impact on further investigations on tissue engineered heart valves.
1086-137 Impairment of Left Atrial Appendage Mechanical 
Function Following Electrical Isolation With Epicardial 
Radiofrequency Bipolar Ablation
Marco A. Zenati, David Schwartzman, University of Pittsburgh, Pittsburgh, PA
Background: Intraoperative, open-chest, beating heart epicardial radiofrequency abla-
tion without atriotomy is an emerging technique for cure of atrial fibrillation. During these
procedures, in order to replicate electrophysiologically the MAZE III procedure, an opera-
tor may ablate at the base of the left atrial appendage (LAA), rendering it electrically iso-
lated, without physically removing or occluding it. Our experience suggests that this
might be dangerous. Methods: In each of 5 large healthy pigs, electrical isolation of the
LAA at its base (junction with left atrial body) was achieved without atriotomy in a beating
heart/open chest preparation with a single application of energy via a bipolar ablation
device. Post-mortem analysis demonstrated the ablation lesion to be transmural and very
discrete, involving <10% of the total LAA volume. LAA, pulmonary vein, transmitral Dop-
pler velocities and electromechanical properties were measured immediately prior to and
after ablation using intracardiac echocardiography (ICE, AcuNav) and electromechanical
mapping (NOGA, Biosense Webster). All animals were in sinus rhythm throughout the
study. Results: There was a marked diminution of LAA peak flow velocity between pre
(0.4 ± 0.2 meters.sec) and post (0.1 ± 0.08 meters/sec) ablation (p<0.05). There was no
significant change in either pulmonary venous or transmitral velocity. NOGA-derived LAA
local linear shortening was markedly diminished in the LAA region (8% ± 3% pre vs 2% ±
1% post-ablation; p<0.05). ICE also demonstrated spontaneous echo contrast not seen
before. Conclusions: Electrical isolation of the LAA produces mechanical paralysis, dila-
tation, and blood stasis. It is reasonable to hypothesize that these changes would be clin-
ically prothrombotic. If an electrically isolated LAA is not to be excised, its orifice should
be carefully occluded.
1086-138 In Which Patients Does Artificial Renal Support Really 
Help After Cardiac Surgery?
Marzia Leacche, Wolfgang C. Winkelmayer, Subroto Paul, Julie Lin, Tomislav Mihaljevic, 
James D. Rawn, John G. Byrne, Brigham and Women's Hospital, Boston, MA
Objective: We developed a scoring system to predict outcome in patients who develop
acute renal failure (ARF) requiring artificial renal support after cardiac surgery, thereby
providing a tool to guide whether or not intensive artificial renal support therapy is justi-
fied. 
Methods: From 01/92-07/01, 136/14,000 (0.9%) patients developed ARF requiring artifi-
cial renal support following cardiac surgery. Fifty-five (40%) underwent CABG/valve, 39
(29%) isolated CABG, 21 (15%) isolated valve, 12 (9%) heart transplant and 9 (6%) other
procedures. Multivariate logistic regression, based on pre-dialysis parameters, was used
to construct a prediction score for operative mortality for those patients with ARF requir-
ing artificial renal support.
Results: The overall operative mortality (OM) was 58% (70/136). From the logistic
regression model (Table) we assigned a score based on the presence of independent
predictors of OM. Higher scores strongly predicted OM. Among the 54 patients with a
score >3 prior to artificial renal support, OM was 85% (115/136) (Specificity 95%). The
positive predictive value was 94%. In patients with score <1, OM was 18% (24/136).
Conclusions: The scoring system represents a simple and accurate tool for predicting
OM in cardiac surgery patients who develop ARF prior to the institution of resource inten-
sive artificial renal support. Thus, in patents with high scores, artificial renal support is
associated with exceedingly high OM and may not be justified. 
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(NL:AR)
NL AR
TIMP-
1
14 0.9:1 0.6:1 1.5:1
25 2.3:1 1.0:1 2.2:1
45 2.4:1 1.7:1 1.4:1
Avg Ratio 1.7:1 
(p=.01)
TIMP-
2
14 1.0:1 1.0:1 1.1:1
25 2.6:1 1.6:1 1.6:1
45 1.7:1 1.2:1 1.3:1
Avg Ratio 1.3:1 
(p=.06)
Multivariate Predictors of Operative Mortality
Patient Characteristics OR CI P Value Points Assigned
Pre Dialysis Coma 9.6 2.3-39 0.001 2
Preop Creatinine <1.5 mg/dL 5.0 2.0-12 0.0007 1
Preop Hypertension 4.4 1.6-12 0.004 1
Pre Dialysis Sepsis 6.4 2.2-18 0.0005 1
Pre Dialysis Total Bilirubin>2 mg/dL 5.6 2.1-15 0.0006 1
